Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![dividendology Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1509705643418128399.png) Dividendology [@dividendology](/creator/twitter/dividendology) on x 81.1K followers
Created: 2025-07-15 16:26:14 UTC

2️⃣ Merck $MRK

📉 Down XX% YoY
💸 Yield: XXX%
💵 FCF Payout Ratio: XX%
🚨 Patent risk: Keytruda expires after 2027

🧬 Recent $10B buyout of Verona Pharma to boost pipeline.

![](https://pbs.twimg.com/media/Gv6SkoVWYAA-aiX.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945157970116943953/c:line.svg)

**Related Topics**
[acquisition](/topic/acquisition)
[$10b](/topic/$10b)
[$mrk](/topic/$mrk)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/dividendology/status/1945157970116943953)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

dividendology Avatar Dividendology @dividendology on x 81.1K followers Created: 2025-07-15 16:26:14 UTC

2️⃣ Merck $MRK

📉 Down XX% YoY 💸 Yield: XXX% 💵 FCF Payout Ratio: XX% 🚨 Patent risk: Keytruda expires after 2027

🧬 Recent $10B buyout of Verona Pharma to boost pipeline.

XXXXX engagements

Engagements Line Chart

Related Topics acquisition $10b $mrk stocks healthcare

Post Link

post/tweet::1945157970116943953
/post/tweet::1945157970116943953